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Background and purpose   Deep vein thrombosis is common after 
total joint replacement. It is frequently asymptomatic, and it is 
unclear whether this leads to longer-term problems such as post-
thrombotic syndrome and leg ulceration. We investigated whether 
the postoperative prevalence of ulceration in patients who had 
undergone primary total hip replacement (THR) or total knee 
replacement (TKR) was higher than that found in a control group 
who had not undergone total joint replacement.
Methods   The study group consisted of patients who had under-
gone THR or TKR at one orthopedic center 12–16 years previ-
ously without routine chemothromboprophylaxis, and who had 
not undergone revision surgery. The control group was recruited 
via primary care. All participants were recruited by post and 
asked to complete a questionnaire. Age- and sex-adjusted preva-
lence of self-reported leg ulceration was calculated, and logistic 
regression was used to determine whether there were any associa-
tions between THR or TKR and leg ulceration.
Results   Completed questionnaires were received from 441 
THR patients (54% response rate), 196 TKR patients (48%) and 
967 control participants (36%). No statistically significant dif-
ferences in age- and sex-adjusted prevalence of ulceration were 
found between the groups, for either lifetime prevalence or preva-
lence over the previous 15 years.
Interpretation   Patients who undergo THR and TKR without 
chemothromboprophylaxis are unlikely to be at a higher risk of 
long-term venous ulceration than the normal population. 

Deep  vein  thrombosis  (DVT)  is  common  after  total  hip 
replacement (THR) and total knee replacement (TKR) (Geerts 
et al. 2001). This is frequently asymptomatic, and it is unclear 
whether there are any longer-term implications of DVT identi-
fied only by venography, in terms of patient morbidity such as 
post-thrombotic syndrome (PTS) (Cordell-Smith et al. 2004). 
Chemothromboprophylaxis reduces rates of DVT, but there 
is no evidence that it reduces deaths from pulmonary embo-
lism (PE) or deaths for any reason (Atkins 2010). In fact, it 
has been suggested to increase mortality after THR and TKR 
(Sharrock et al. 2008). This would be difficult to test in a ran-
domized controlled trial, as postoperative mortality is very 
low after joint replacement ( Parry et al. 2008, Cusick and 
Beverland 2009).
PTS is a collection of symptoms including swelling, pain, 
and—in severe cases—venous ulceration. The symptoms of 
PTS are not uniformly defined, and it is therefore difficult 
to  compare  results  from  different  studies  (Kahn  2009).  It 
is unclear whether patients who have had TKR or THR are 
more at risk of PTS than the general population, and whether 
there are long-term consequences of asymptomatic DVT in 
this group. Debate about whether to use routine chemothrom-
boprophylaxis is centered mainly on postoperative DVT and 
pulmonary embolism (Atkins 2010), but the long-term conse-
quences of thrombus are also being increasingly considered 
(Campbell et al. 2010). This is important, both in the choice of 
thromboprophylaxis and in ensuring that patients are informed 
about all potential adverse effects of joint replacement. 
Ulceration has been used previously as a “hard” endpoint 
of PTS to investigate medium-term outcomes of TKR in a 
study that found no association between postoperative DVT 
identified by venography and ulceration 5 years after surgery 
(Muller et al. 2001). Although in that study the prevalence of 
leg ulceration was considered to be similar to the estimated 
prevalence of ulceration in the general population, both PTS 
and leg ulceration are found frequently in the general popula-
tion (Kahn 2006), and it is difficult to determine whether TKR 
and THR patients are at an increased risk without a control 
group. 
In this study, we built on the work performed by Muller et al. 
(2001) by looking at the 12–16-year postoperative prevalence 
of leg ulceration in both TKR and THR patients. The inclusion 
of a control group allowed comparison of the prevalence of leg 
ulceration to that of the general population, in order to identify 
whether THR or TKR is indeed a risk factor for leg ulceration. 472  Acta Orthopaedica 2011; 82 (4): 471–474
Patients and methods
Between  1993  and  1996,  956  patients  underwent  primary 
unilateral TKR and 1,727 patients underwent primary unilat-
eral THR at one elective orthopedic center (Blom et al. 2003, 
2006). These patients received no routine chemothrombopro-
phylaxis.
Of these patients, 790 TKR patients and 1,240 THR patients 
responded to a cross-sectional postal survey in 2001 (Wylde et 
al. 2009) and they were used as the basis for this study. After 
excluding deceased and untraceable patients, 410 TKR and 
813 THR patients were invited to take part by post, with a 
single reminder sent to non-responders. In the questionnaire, 
patients were asked if they had had leg ulcers before their joint 
replacement, since their joint replacement, and presently, on 
either the operated leg or the contralateral leg. 
Control participants were recruited through GP surgeries in 
the Bristol area. Healthy controls were defined as individuals 
who had not had either THR or TKR. Questionnaires were 
posted to randomly selected patients who were in the same 
age group as the patients. The control participants were asked 
in the questionnaire if they had ever had ulcers on either leg, 
and if so, whether these had occurred within the previous 15 
years. 
Statistics
Due  to  differences  in  age  distribution  between  the  three 
groups, the lifetime prevalence of ulceration was adjusted by 
standardizing the age and sex distributions of the THR and 
TKR groups to that of the controls. 95% confidence intervals 
(CIs) for proportions were calculated using the Wilson method 
(Wilson 1927). Logistic regression with CIs was used to deter-
mine whether there were associations between THR or TKR 
and leg ulceration. We used SPSS software version 16.0.
Ethics
Ethical approval was obtained from the Southmead Research 
Ethics Committee (08/H0102/62). 
Results
Response rates
Of the 813 THR patients who were invited to participate, 485 
responded to the postal survey. Of the responders, 44 were 
excluded due to revision surgery or dementia, giving a final 
total of 441 THR patients (54% response rate). Of the 410 
TKR patients who were invited to participate, 220 responded 
to the postal survey, and of these, 24 were excluded due to 
revision surgery or dementia, giving a final total of 196 TKR 
patients (48% response rate). Overall, 2,700 healthy controls 
were invited to participate, and 978 responses were received; 
of these, 6 were not eligible due to having had TKR or THR 
and a further 5 were excluded as they did not specify their 
ages. There were therefore 967 healthy controls, correspond-
ing to a response rate of 36%.
Demographics 
Before adjustment, the median age of the TKR patients was 
81 (33–98) years, that of ofthe THR patients was 78 (30–99) 
years, and that of the healthy controls was 72 (34–96) years 
(Table 1). 
The median time from surgery until follow-up was 14 (12–
16) years for both TKR patients and THR patients. The contra-
lateral joint had also been replaced in 72% of the TKR patients 
and in 53% of the THR patients.
For the THR patients, the median age of responders to this 
study at the time of surgery was 64 (17–86) years, as com-
pared to a median age of 69 (17–91) years for all patients who 
underwent primary THR at the center 12–16 years previously. 
For TKR patients, the median age of responders at the time of 
surgery was 67 (19–86) years, as compared to a median age 
of 72 (19–90) years for all patients who underwent primary 
TKR at the center 12–16 years previously. However, given the 
long-term nature of this study, it was to be expected that there 
would be loss of potential participants due to morbidity and 
mortality, and that this would be seen particularly in the more 
elderly patients. Sensitivity analysis was performed to identify 
non-response bias. When analysis was adjusted to standardize 
the age and sex distribution of responders to that of all those 
invited to participate, the results did not change statistically 
significantly. 
Lifetime prevalence of ulceration 
The age- and sex-adjusted lifetime prevalence of ulceration, 
open and healed, in the 3 groups was similar (Table 2). The 
unadjusted lifetime prevalence of ulceration was 7.6% (CI: 
5.4–11) for the THR group and 12% (7.7–17) for the TKR 
group. 
Table 1. Numbers of participants in each group, according to age
  Age (years)
Group  females  30–39  40–49  50–59  60–69  70–79  80–89  90–100  Total
Control group  56%  14 (1.4%)  17 (1.8%)  123 (13%)  194 (20%)  361 (37%)  211 (22%)  47 (4.9%)  967
THR patients  62%    4 (0.9%)    8 (1.8%)    17 (3.9%)    81 (18%)  150 (34%)  150 (34%)  31 (7.0%)  441 
TKR patients   65%    2 (1.0%)    0 (0.0%)      5 (2.6%)    13 (6.6%)    68 (35%)    88 (45%)  20 (10%)  196Acta Orthopaedica 2011; 82 (4): 471–474  473
Postoperative prevalence of ulceration 
For the purposes of analysis, ulceration within the previous 
15 years in the control group was considered equivalent to 
postoperative ulceration in the study group. The prevalence 
of ulceration was highest in the TKR group, with considerable 
overlap in the confidence intervals (Table 3). The unadjusted 
postoperative prevalence of ulceration was 5.7% (CI: 4.1–8.6) 
for the THR group and 9.9% (6.4–15) for the TKR group. 
Risk of ulceration 
Logistic regression did not show any evidence that patients 
who had had a THR and TKR were at an increased risk of 
leg ulceration postoperatively, compared to healthy controls 
(Table 4). The 95% confidence intervals for the odds ratios 
contained the value of 1, indicating that it is plausible at the 
0.05 level that those who had had a THR or a TKR were as 
likely to develop a leg ulcer as those in the control group. 
However,  increasing  age  was  found  to  be  associated  with 
increased risk of leg ulceration. 
Discussion 
It has been reported previously that there is no increased risk 
of venous ulceration 5–12 years after THR, or 5 years after 
TKR, when compared to an estimated incidence in the gen-
eral population (Muller et al. 2001, Mehta et al. 2003). This 
study expands on these previous findings, both by extending 
the time period of the study and by including a control group 
who had not undergone THR or TKR. We found no associ-
ation between having had a TKR or a THR and having leg 
ulceration by 12–16 years after surgery. 
Previous  studies  have  investigated  differences  between 
patients  who  have  had  postoperative  DVT  identified  by 
venography and those who have not had DVT. An associa-
tion between asymptomatic DVT and later development of 
PTS was identified in a meta-analysis, which included both 
abdominal and joint surgery, but the study was limited by a 
lack of consistency in methods and definitions between the 
few papers published on the subject (Wille-Jorgensen et al. 
2005). 1 year after surgery, no difference was found in mor-
bidity or patient outcome between THR and TKR patients 
who had had a postoperative DVT identified by venography 
and those who had not (Cordell-Smith et al. 2004); nor was 
DVT that was diagnosed by venous ultrasonography postop-
eratively—whether symptomatic or not—found to be predic-
tive of PTS in a group of TKR patients 1–7.5 years after sur-
gery (McAndrew et al. 2010), or associated with the incidence 
or prevalence of leg ulcers 5 years after TKR (Muller et al. 
2001). Mant et al. (2008) found a low frequency of PTS 2–4 
years after THR in patients who received had chemothrombo-
prophylaxis; however, there was no control group that did not 
receive thromboprophylaxis. 
Kim and Kim (2002) and Kim et al. (2003) reported that 
DVT  was  found  in  39–45%  of  patients  after  TKR  and  in 
20–27% after THR; at 6-month follow-up, it was found that 
these thrombi had all spontaneously and completely resolved. 
It is likely that the patients in our study would have had similar 
rates of asymptomatic DVT. 
The patients in the study group were asked about ulceration 
before and after their surgery, while individuals in the control 
group were asked if they had had an ulcer within the previous 
15 years or more than 15 years ago. We recognize that recall 
of the timing of events that long ago is unlikely to be accurate, 
and that there are also problems with self-reporting of ulcer-
ation. In a previous study, of 43 patients who reported having 
had ulceration, 12 did not have true venous ulceration (Mehta 
et al. 2003). It is likely that the true incidence of ulceration 
is lower than that reported in our study. However, the control 
group and patient group data were obtained from using almost 
identical questions, thus allowing direct comparison between 
the groups. 
In this study, we found no evidence that patients who under-
went THR or TKR without chemothromboprophylaxis were 
at higher risk of venous ulceration than the normal population 
by 12–16 years postoperatively. However, a larger sample size 
would be needed to enable detection of a small difference with 
any  degree  of  statistical  confidence.  Recommendations  for 
further work would include a large-scale prospective cohort 
study to assess the long-term incidence of venous ulceration in 
joint replacement patients with confirmed postoperative DVT 
and in those without DVT.
VW and AWB designed the study. VCG and VW gathered the data. AJS, 
VCG, and VW analyzed the data. VCG wrote the initial draft. All authors 
were involved in revising the manuscript.
This study was supported by a research grant from the North Bristol Trust 
Research and Innovation Small Grant Scheme. The current positions of Vikki 
Table  2.  Lifetime  prevalence  of  ulceration 
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  Prevalence  95% CI
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THR patients  5.9%  4.0–8.6
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